KeraVision Financial and Business Information

Stock Information:

• Common Stock 18,860,632 issued, 5,844,681 more authorized.
• Series A Preferred 0 issued, 30,000 authorized.
• Series B Preferred 662,500 authorized, 537,385 issued.
• Follow-on Offering, 8/12/1999 Underwriters, Fees, Lock-up, Over-allotment.
• Stockholder Rights Plan For a brief discussion, Click Here.
• Major Institutional Shareholders
  • Through SEC Filings
  • Through Market Guide/Vickers

Summary Consolidated Financial Data

• Through 6/30/99
• Through 9/30/99
• Through 12/31/99

Results of Operations: Costs and Income

• Through 6/30/1999
• Through 9/30/1999
• Through 12/31/1999 New

Marketing and Sales  New

• Plans and Agreements

Patents and Proprietary Rights

Manufacturing: Intacs and Surgical Instruments

• What is PMMA?

Corporate Information  Updated

• Employees, Properties, Management, Directors

Europe, Canada and Asia

• Approvals and Marketing Efforts